Bioceltix (WAR:BCX) Tax Provision : zł-0.06 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Bioceltix Tax Provision?

Bioceltix's tax provision for the three months ended in Sep. 2024 was zł-0.04 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was zł-0.06 Mil.

Bioceltix Tax Provision Historical Data

The historical data trend for Bioceltix's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioceltix Tax Provision Chart

Bioceltix Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

0.02

-0.04

0.05

0.01

Bioceltix Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Provision	Get a 7-Day Free Trial													0.03	0.01	-0.02	-0.01	-0.04

Bioceltix Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.06 Mil.

Bioceltix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioceltix SA (WAR:BCX) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bierutowska 57-59 Street, Wroclaw, POL, 51-317

Website

https://www.bioceltix.com

Bioceltix SA develops therapies for veterinary use that harness the immunomodulatory properties of mesenchymal stem cells. Its pipeline products include BCX-CM-J for Degenerative joint lesions; BCX-CM-S for Autoimmune and inflammatory diseases in dogs; BCX-EM for Tendon damage and BCX-FM for Gingivostomatitis.